Teenagers from 15 should be given MenB vaccine, say UK experts after Kent outbreak
Advisers are asking the government to consider introducing the jabs following concerns over a meningitis B outbreak in Kent earlier this year, in which two people died.
The recommendation by UK experts to vaccinate teenagers against MenB, following a concerning outbreak in Kent, highlights the ongoing battle against meningitis. The disease, which can be deadly, has seen a resurgence in cases in recent years, prompting health officials to reassess vaccination strategies. The proposed vaccination for 15-year-olds aims to bolster immunity in a demographic particularly vulnerable to the disease.
The Kent outbreak, which resulted in two fatalities, served as a stark reminder of the risks associated with meningitis B. This serogroup has been responsible for the majority of meningitis cases in the UK in recent years, and the outbreak underscored the need for effective preventive measures. The UK's vaccination policy has previously focused on immunizing infants against MenB, but the current proposal seeks to extend protection to teenagers, who are also at risk.
As the UK government considers the experts' recommendation, it's essential to monitor the response and potential implementation of the MenB vaccine for 15-year-olds. The decision will likely depend on various factors, including the cost-effectiveness of the vaccine and the potential impact on public health. What's next to watch is whether the government will adopt the recommendation and, if so, how the vaccination program will be rolled out and communicated to the public.
Originally reported by bbc.co.uk. NewsLoop adds analysis for general news readers.